Clinical Research Directory
Browse clinical research sites, groups, and studies.
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
Sponsor: Inova Health Care Services
Summary
This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene expression and serve as molecular biomarkers found in the circulation.
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2025-02-06
Completion Date
2029-10-01
Last Updated
2026-03-25
Healthy Volunteers
No
Conditions
Locations (7)
Children's Hospital Colorado
Aurora, Colorado, United States
University of Michigan
Ann Arbor, Michigan, United States
Columbia University
New York, New York, United States
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Vanderbilt University
Nashville, Tennessee, United States
Texas Children's Hospital
Houston, Texas, United States
Inova Health System
Falls Church, Virginia, United States